---
layout: post
title: "Outsourcing Facility Fee Rates for Fiscal Year 2026"
date: 2026-02-04 21:48:57 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-14410
original_published: 2025-07-30 00:00:00 +0000
significance: 8.00
---

# Outsourcing Facility Fee Rates for Fiscal Year 2026

**Published:** February 04, 2026 21:48 UTC
**Source:** Federal Register
**Original Published:** July 30, 2025 00:00 UTC
**Document Number:** 2025-14410

## Summary

The Food and Drug Administration (FDA or we) is announcing the fiscal year (FY) 2026 rates for the establishment and reinspection fees related to entities that compound human drugs and elect to register as outsourcing facilities under the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FD&C Act authorizes FDA to assess and collect an annual establishment fee from outsourcing facilities, as well as a reinspection fee for each reinspection of an outsourcing facility. This document establishes the FY 2026 rates for the small business establishment fee ($6,829), the non-small business establishment fee ($20,726), and the reinspection fee ($20,486) for outsourcing facilities; provides information on how the fees for FY 2026 were determined; and describes the payment procedures outsourcing facilities should follow.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/07/30/2025-14410/outsourcing-facility-fee-rates-for-fiscal-year-2026)
- API: https://www.federalregister.gov/api/v1/documents/2025-14410

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
